申请人:UNIVERSITE DE GENEVE
公开号:EP3248604A1
公开(公告)日:2017-11-29
The present invention relates to inhibitors of WNT-TCF signalling and compositions thereof. The invention further relates to use of those inhibitors of WNT-TCF signalling and compositions thereof for the treatment and/or prevention and/or prevention of recurrence of a WNT-activated cancer and/or a cancer associated with the cancer stem cells. the active compounds are certain cardenolides and bufanolides.
本发明涉及WNT-TCF信号的抑制剂及其组合物。本发明还涉及将这些 WNT-TCF 信号抑制剂及其组合物用于治疗和/或预防和/或防止 WNT 激活的癌症和/或与癌症干细胞相关的癌症复发。